Tiziana Life Sciences Ltd
TLSA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001723069
In the last 90 days, Tiziana Life Sciences Ltd insiders filed 4 open-market purchases and 0 sales; 30 institutions reported holding it in 13F filings for Q2 2026, worth $3.10M in total; no superinvestor holds it.
Q1 2022 vs. Q4 2021
How the institutions holding Tiziana Life Sciences Ltd changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 23 | 23 | 0 |
| Shares | 5.82M | 5.73M | −89.6K (−1.5%) |
| Value | $5.63M | $6.02M | +$385.0K (+6.8%) |
New holders (7)
Institutions that held Tiziana Life Sciences Ltd at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| JPMorgan Chase & Co | 86,258 | $91.0K | 0.00% |
| Warberg Asset Management LLC | 22,000 | $23.0K | 0.01% |
| Barclays PLC | 17,500 | $18.0K | 0.00% |
| Citadel Advisors LLC | 13,973 | $15.0K | 0.00% |
| Credit Suisse AG | 10,588 | $11.0K | 0.00% |
| Cutler Group LP | 1,000 | $1.00K | 0.00% |
| IFP Advisors, Inc | 500 | $1.00K | 0.00% |
Sold out (7)
Institutions that held Tiziana Life Sciences Ltd at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Renaissance Technologies LLC | 78,267 | $75.0K |
| Jane Street Group, LLC | 49,439 | $47.0K |
| Susquehanna International Group, LLP | 41,028 | $39.0K |
| BlackRock Inc. | 30,619 | $29.0K |
| Goldman Sachs Group Inc | 25,370 | $24.0K |
| Cypress Capital Management LLC (WY) | 5 | $0 |
| Advisor Group Holdings, Inc. | 5 | $0 |